Day: November 25, 2014

Targeting drug development

Muthiah Vaduganathan and Vinay Prasad in a JAMA Viewpoint: From a pragmatic standpoint, drug development programs conducted in broad populations poorly prioritize which patients should start therapy first. If

READ MORE

The formulary wars

Robert Langreth reports: Unless more is done about a wave of new and expensive drugs, some priced at as much as $50,000 a month, Miller

READ MORE

Regulating innovation

Paul Demko reports: [CMS] wants to require insurers to establish “pharmacy and therapeutics” committees that would meet at least four times a year to review drug

READ MORE

Is Pay for Performance Corrupting Medicine?

Pamela Hartzband and Jerome Groopman have a recent New York Times editorial arguing that quality incentives for doctors are corrupting medicine: [F]inancial forces largely hidden from the public are beginning

READ MORE
Subscribe

Email Address*